Risk of cutaneous malignant melanoma in patients with celiac disease: a population-based study.

PubWeight™: 0.77‹?›

🔗 View Article (PMC 4104240)

Published in J Am Acad Dermatol on May 01, 2014

Authors

Benjamin Lebwohl1, Hanna Eriksson2, Johan Hansson2, Peter H R Green3, Jonas F Ludvigsson4

Author Affiliations

1: Celiac Disease Center, Department of Medicine, Columbia University College of Physicians and Surgeons, New York, New York; Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
2: Department of Oncology-Pathology, Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden.
3: Celiac Disease Center, Department of Medicine, Columbia University College of Physicians and Surgeons, New York, New York.
4: Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; Department of Pediatrics, Örebro University Hospital, Örebro, Sweden. Electronic address: jonasludvigsson@yahoo.com.

Articles cited by this

Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med (2010) 67.34

Completeness of the Swedish Cancer Register. Non-notified cancer cases recorded on death certificates in 1978. Acta Radiol Oncol (1984) 5.36

The prevalence of celiac disease in the United States. Am J Gastroenterol (2012) 4.77

Increased prevalence and mortality in undiagnosed celiac disease. Gastroenterology (2009) 3.73

Small-intestinal histopathology and mortality risk in celiac disease. JAMA (2009) 3.35

Cancer incidence in a population-based cohort of individuals hospitalized with celiac disease or dermatitis herpetiformis. Gastroenterology (2002) 2.94

Clinical practice. Celiac disease. N Engl J Med (2012) 2.79

International trends in the incidence of malignant melanoma 1953-2008--are recent generations at higher or lower risk? Int J Cancer (2012) 2.07

Risk of malignancy in patients with celiac disease. Am J Med (2003) 1.85

Low risk of gastrointestinal cancer among patients with celiac disease, inflammation, or latent celiac disease. Clin Gastroenterol Hepatol (2011) 1.85

Risk of non-Hodgkin lymphoma in celiac disease. JAMA (2002) 1.81

Validation study of villous atrophy and small intestinal inflammation in Swedish biopsy registers. BMC Gastroenterol (2009) 1.79

Emerging trends in the epidemiology of melanoma. Br J Dermatol (2014) 1.31

Risk of malignancy in diagnosed coeliac disease: a 24-year prospective, population-based, cohort study. Aliment Pharmacol Ther (2004) 1.24

Risk of lymphoproliferative malignancy in relation to small intestinal histopathology among patients with celiac disease. J Natl Cancer Inst (2011) 1.23

Characteristics and management of immunerelated adverse effects associated with ipilimumab, a new immunotherapy for metastatic melanoma. Cancer Manag Res (2012) 1.08

Immune alterations in malignant melanoma and current immunotherapy concepts. Expert Opin Biol Ther (2013) 0.91

Association between ipilimumab and celiac disease. Mayo Clin Proc (2013) 0.82

Immunology of melanoma. Clin Dermatol (2013) 0.81